Essayer OR - Gratuit
APAC focuses on bridging eye care gaps
BioSpectrum Asia
|BioSpectrum Asia Sep 2025
Roche APAC Vision Health Survey in 2025 reveals a stark disconnect between vision health concerns and preventive action across Asia Pacific (APAC) - while 91 per cent of adults over 40 express concerns about their vision health, only 28 per cent report undergoing annual or more frequent eye exams.
-
Despite significant advancements in eye care, technological breakthroughs, and increasing global awareness, vast inequities persist in access to quality vision services. Thus, there is a clear need to include eye care in public health plans with coordinated, and accountable pathways. Let's take a look at the current challenges and future possibilities for all stakeholders to prioritise and invest in eye healthcare in APAC.
Over 2.2 billion people globally live with some form of vision impairment or blindness, and alarmingly, at least 1 billion of these cases could have been prevented or are still unaddressed. The challenge is not merely about understanding the scope of the problem, but about transforming insights into practical, scalable, and sustainable solutions. Turning data, research, and innovations into meaningful action lies at the heart of efforts to advance vision health globally.
At the macro level, the World Health Organization (WHO) estimates that poor vision leads to over $400 billion in lost productivity annually. The economic and social costs extend further when factoring in caregiving burdens and reduced independence among older adults. Many eye diseases that develop with age are impossible for individuals to detect on their own without proper vision screening, such as a dilated eye exam. As people get older, those who suffer from vision loss face an increasing overall burden from it.
Cette histoire est tirée de l'édition BioSpectrum Asia Sep 2025 de BioSpectrum Asia.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE BioSpectrum Asia
BioSpectrum Asia
UK transforms mental healthcare with new strategy
Frontline workers, clinicians and mental health experts are being invited to share their views on how to transform mental healthcare for children and adults in England, as the government launches a call for evidence to shape its once-in-a-generation crossgovernment mental health strategy.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Australia Budget 2026-27: Investing in Care, Health and Innovation.
The Australian Federal Budget 2026-27, presented by the Albanese Government, places strong emphasis on healthcare, aged care, T disability services, research, innovation and social equality.
4 mins
BioSpectrum Asia June 2026
BioSpectrum Asia
Gavi proposes new incentives for advancing vaccine manufacturing in Africa
With Gavi's African Vaccine Manufacturing Accelerator (AVMA) expected to make its first cash disbursement to an African vaccine manufacturer in the second half of 2026, Gavi, the Vaccine Alliance has proposed further measures totaling $189 million of additional investment to further aid development of Africa's vaccine manufacturing sector.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
New WHO online course strengthens good practices in clinical trials
High-quality clinical trials are essential for generating reliable evidence to inform health policy, clinical practice and public trust in science.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
World Bank approves $225 M to improve healthcare in Côte d'Ivoire
The World Bank has approved $225 million in financing to help Côte d'Ivoire improve the delivery of quality health, nutrition, and early childhood development services for millions of people, particularly for women, children, and vulnerable households.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Nona Biosciences appoints Dr Josh Xiao as CSO
Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, has announced the appointment of Dr Josh Xiao as Chief Scientific Officer (CSO). Dr Xiao will be based in both the US and China and report directly to Dr Di Hong, Chief Executive Officer of Nona Biosciences.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Korea lays focus on stabilising medical product supply
The Ministry of Health and Welfare (MoHW), South Korea government, recently held its 7th meeting with healthcare and pharmaceutical associations, bringing together the Ministry of Trade, Industry and Resources (MOTIR), and the Ministry of Food and Drug Safety (MFDS).
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Formosa Pharma partners with SERI to advance novel ophthalmic formulations for corneal diseases
Taiwan-based Formosa Pharmaceuticals, Inc. and the Singapore Eye Research Institute (SERI) have announced a strategic research collaboration to develop next-generation ophthalmic formulations.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Academy of Digital Health Sciences launches two new courses in AI
Academy of Digital Health Sciences (ADHS), based in India, has announced the launch of its landmark 'AI for All' Mission, a bold, mission-driven programme designed to democratise artificial intelligence (AI) across global healthcare systems.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
AstraZeneca Korea names Ohad Goldberg as new Country President
AstraZeneca Korea has appointed Ohad Goldberg, former President of AstraZeneca Israel, as its new Country President, effective May 1.
1 min
BioSpectrum Asia June 2026
Listen
Translate
Change font size
